BIOSTONE CO. LTD.
Biostone Biologics
The forefront of next generation synthetic bone graft products The Company Established in 2017, Biostone utilises proprietary technologies to produce next generation synthetic bone graft products that work in harmony with natural bone remodelling processes. The Product Our new product, si-Mochi, is osteoconductive, osteosimulative and is designed to enhance osteocytes formation - ready to use...
- Type
- Manufacturer
- Location
- Nottingham Nottinghamshire, United Kingdom
- Founded
- 2016
- Website
- https://biostone.co.uk
- Categories
- Medical & Healthcare Supplies
Listed in a source registry
Verified facts
- domain-registered (green), checked 2026-08-12 Domain registry record
- fda-registered (green), checked 2026-08-12 FDA
- debarment-clear (green), checked 2026-08-12 OpenSanctions
- sanctions-clear (green), checked 2026-08-12 OpenSanctions
- ch-active (green), checked 2026-08-12 Companies House
- facility-registered (green), checked 2026-08-07 US FDA device establishment registration (openFDA)
- registered-since (green), checked 2016-11-29 Companies House free company data product (UK)
- directors-on-file (green), checked 2026-08-12 Companies House
- officer-appointed (green), checked 2026-08-12 Companies House (officers)
- leadership-on-record (green), checked 2026-08-12 Companies House (officers)
- ownership-on-record (green), checked 2026-08-12 Companies House (PSC)
- annual-accounts-filed (green), checked 2026-08-12 Companies House (accounts)
Claimed certifications
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)